A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency-Reference-Cited by-同舟云学术

A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency

Published:2022-05-02 Issue:4 Volume:28 Page:523-531
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Payne Jeanette¹,Batsuli Glaivy²^ORCID,Leavitt Andrew D.³,Mathias Mary⁴,McGuinn Catherine E.⁵^ORCID

Affiliation:

1. Department of Paediatric Haematology Sheffield Children's NHS Foundation Trust Sheffield UK

2. Department of Pediatrics Division of Pediatric Hematology and Oncology Emory University Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta Atlanta Georgia USA

3. Departments of Laboratory Medicine & Medicine (Hematology) University of California San Francisco San Francisco California USA

4. Great Ormond Street Hospital for Children NHS Foundation Trust Haemophilia Comprehensive Care Centre London UK

5. Department of Pediatrics Division of Pediatric Hematology Oncology Weill Cornell Medicine New York New York USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14570

Reference22 articles.

1. Guideline for the diagnosis and management of the rare coagulation disorders

2. National Haemophilia Foundation.Factor X deficiency.2021.https://www.hemophilia.org/bleeding‐disorders‐a‐z/types/other‐factor‐deficiencies/factor‐xAccessed.

3. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

4. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation

5. Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, Laboratory Aspects and Management of Factor X Deficiency;Seminars in Thrombosis and Hemostasis;2024-08-29

2. Fitusiran reduces bleeding in factor X–deficient mice;Blood;2024-07-11

3. Plasma‐derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency;Haemophilia;2023-10-30

4. Clotting Factor Deficiencies as an Underlying Cause of Abnormal Uterine Bleeding in Women of Reproductive Age: A Literature Review;Life;2023-06-05

5. Congenital Factor X Deficiency, Diagnosis, and Management;Congenital Bleeding Disorders;2023